Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 35 clinical trials
Efficacy of Spartalizumab Across Multiple Cancer-types in Patients With PD1-high mRNA Expressing Tumors

This is an open-label, single arm, non-randomized, multicenter phase II study to evaluate the efficacy of spartalizumab in monotherapy in metastatic patients with Programmed Death-1 (PD1)-high-expressing tumors.

measurable disease
alopecia
cancer
  • 0 views
  • 22 Aug, 2021
  • 10 locations
GammaPod Registry and Quality of Life Nomogram (GCC 1876)

This study is a prospective, single arm study (registry) summarizing patient-level adverse-event and tumor outcomes as well as a number of feasibility and dosimetric characteristics of delivering a single-fraction boost with the GammaPod.

cancer
lumpectomy
breast cancer
mastectomy
  • 0 views
  • 02 Mar, 2022
  • 4 locations
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

The purpose of ORACLE is to demonstrate the ability of a novel ctDNA assay developed by Guardant Health to detect recurrence in individuals treated for early-stage solid tumors. It is necessary that ctDNA test results are linked to clinical outcomes in order to demonstrate clinical validity for recurrence detection and …

adenocarcinoma
HER2
pancreatic adenocarcinoma
endometrial carcinoma
squamous cell carcinoma
  • 0 views
  • 04 Oct, 2021
  • 1 location
Study of the Safety of MRI Scans in People Who Have Breast Tissue Expanders After Mastectomy

The purpose of this study is to find out whether it is safe to perform MRI scans in people who have breast tissue expanders in place.

Accepts healthy volunteers
mastectomy
  • 0 views
  • 18 Jun, 2022
  • 3 locations
Immune Response to Anti-HER2 Therapies in Patients With HER2-Positive Stage I-IV Breast Cancer

This study gathers information from the blood cells and tumor tissue during treatment with anti-HER2 therapies, such as trastuzumab, pertuzumab, lapatinib, or neratinib, in patients with HER2 positive stage I-IV breast cancer who are scheduled to start anti-HER2 therapy. The information gained from this study may help researchers better understand …

breast cancer
biospecimen collection
progesterone receptor
adenocarcinoma of the breast
immunohistochemistry
  • 0 views
  • 22 Aug, 2021
  • 1 location